Raymond Optimistic on Aerospace Demand, R&D Pressures Margins

Raymond Limited — Q1 FY27 Earnings Conference Call (Aug 07, 2026)

1. Overall Tone of Management

Optimistic. Management repeatedly emphasizes strong demand tailwinds and execution confidence, using language such as “remain optimistic,” “sharp demand revival,” “robust 10-year order book,” and “we are well positioned.” Even when acknowledging margin compression, they frame it as temporary due to “major R&D expenses” with stabilization expected.

2. Key Themes from Management Commentary

• Macro/trade tailwinds driving exports: Management cites favorable global trade shifts (CETA with UK effective 15 July 2026; “rollback of restrictive U.S. tariffs,” “destocking cycles concluding”) supporting engineering export demand revival.
• Aerospace ramp-up converting backlog to executable volumes: They highlight OEM ramp-up, easing of raw material constraints, and conversion of “record order books into executable assembly volumes.”
• Value-chain upgrade as the core strategy: Transition from standard machining to “high-complexity subsystems, critical aero-engine modules, and precision-engineered assemblies,” with vertical integration (heat treatment, special processes) to improve customer confidence.
• Margin management via mix + operating leverage, with R&D as a near-term drag: Aerospace EBITDA margin compression is attributed to “temporary compression” from R&D write-offs; Precision margins improve via export volume and cost reduction.
• Diversification via aftermarket rollout: Aftermarket business scheduled for “commercial rollout in Q2 of FY27,” leveraging OEM-grade ecosystem and brand heritage.
• Capex and greenfield execution discipline: INR 1,000 crore 5-year capex plan progressing; Andhra Pradesh greenfield groundwork on track with “commercial production targeted for late 2027.”
• Balance sheet flexibility: Claims “net debt-free” with net cash surplus of INR 129 crores (as of June 2026).

3. Q&A Analysis

Theme A: Equity/warrants & inorganic growth approach

• Core question(s):
• Why did the company issue warrants / how are you evaluating inorganic opportunities given earlier statements that internal accruals and debt capacity were sufficient?
• Management response:
• Warrants are framed as “additional flexibility” to evaluate opportunities across aerospace, auto components, and defence; they will return to markets “as and when we are close to closing.”
• Assessment (evasive/partial/strong):
• Partial/deflecting: No specifics on valuation, target size, or timing; rationale is generic (“business as usual” evaluation).

Theme B: Aerospace supply chain bottlenecks exposure

• Core question(s):
• Are they exposed to the same aerospace supply chain bottlenecks (casting/forging constraints) that caused another supplier to revise expectations?
• Management response:
• They claim limited exposure because “a lot of those kind of businesses haven’t transferred yet” and they are in a backlog-clearing phase; “execution game” framing.
• Assessment:
• Relatively strong but not fully evidenced: No named suppliers/materials; relies on execution/backlog logic.

Theme C: RFQ pipeline conversion timing & margin outlook

• Core question(s):
• How to interpret the aerospace RFQ pipeline (INR 1,632 cr): are they L1, and when will RFQs convert?
• What EBITDA margin should be expected in FY27 (consolidated 12–13% range)?
• Management response:
• RFQs are “live items” and conversion depends on criticality and lag; they emphasize choice (“choice from our side rather than a constraint”) and customer expectation management.
• For margins: “expect the EBITDA margins to have the same trend… keep the same momentum.”
• Assessment:
• Evasive on conversion mechanics: No L1/L2 disclosure; conversion timing remains qualitative.
• Guidance-like but non-quantified: Margin expectation is directional (“same trend”), not a firm number.

Theme D: Aerospace growth, value-chain expansion, certifications

• Core question(s):
• Expected aerospace growth by year-end; plan to move from components to subassemblies.
• Any new certifications (aerospace/medical).
• Management response:
• Aerospace growth: they reference “committed 25% growth” and say they’re “a little bit ahead” in Q1.
• Value chain: “definite goal to go up the value chain,” with special processes and heat treatment in Andhra.
• Certifications: medical certification received “today”; aerospace certifications largely already in place; build-to-spec design certification obtained.
• Assessment:
• Clear on direction; light on quantification: Growth commitment is stated (25%), but year-end revenue estimate is not provided.

Theme E: Order book jump & capacity utilization / greenfield ramp

• Core question(s):
• Order book increased from INR 2,350 cr (5-year) to INR 5,960 cr (10-year): explain.
• Is order book only for existing facility? How much more can existing capacity do?
• Greenfield ramp: approval timelines; when do revenues start?
• Management response:
• Order book horizon changed to 10 years because aerospace is long-term; also clarifies order book is “only for the existing facility” and excludes daily-closed orders.
• Existing facility: they claim improvements via “Parivartan” and expect to exceed INR 600 cr (previous estimate).
• Greenfield: “up to 6 months approval processes,” so “start looking at FY28” for numbers; ramp slowly due to aerospace approvals.
• Assessment:
• Credibility risk: Order book explanation is plausible (horizon change), but the “sequential” inference by analysts is affirmed (“safe to assume”).
• No hard capacity numbers: Existing utilization and incremental revenue capacity remain qualitative.

Theme F: Aftermarket business & consolidated growth potential

• Core question(s):
• Can aftermarket make consolidated growth 20%+? Any margin synergy?
• Management response:
• No numeric guidance: “not going to commit numbers,” but scenario is “much more positive,” citing “massive synergies” and better margin expansion via combined tools/hardware + aftermarket.
• Assessment:
• Non-committal: Strong narrative, no quantified targets.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Aerospace growth commitment: “We have committed 25% growth” (and Q1 is “a little bit ahead”).
• Capex plan: INR 1,000 crore over 5 years (split stated as INR510 cr aerospace and INR430 cr auto).
• Greenfield production timing: commercial production targeted for late 2027.
• Aftermarket rollout timing: “commercial rollout in Q2 of FY27.”
• Net cash: net cash surplus INR 129 cr (as of June 2026).

Implicit signals (qualitative)

• Margins: Management expects EBITDA margin “same trend” and stabilization after R&D write-offs; operating leverage should continue.
• Demand: “strong RFQ activity,” “market is quite large,” and customers rebuilding inventory buffers.
• Execution focus: repeated “execution game” and “don’t disappoint customers” language suggests capacity planning is constrained by delivery reliability rather than demand.
• Greenfield ramp risk acknowledged: approvals and customer qualification can delay revenue ramp; they plan to avoid growth slowdown by improving current facility.

5. Standout Statements (direct / revealing)

• Order book visibility: “robust 10-year order book of INR5,960-plus crores” and “active RFQ pipeline of INR1,632 crores.”
• Margin driver framing (temporary): “EBITDA margins saw temporary compression… incurred major R&D expenses… As these newly developed programs transition into steady-state production, EBITDA margins will stabilize.”
• Aftermarket timing: “commercial rollout in Q2 of FY27.”
• Aerospace supply chain stance: “we are today not exposed as much… this is an execution game.”
• Greenfield approvals: “You can assume that it will have up to 6 months approval processes… start looking at FY28 for numbers.”
• No R&D capitalization: “we don’t capitalize any R&D expense… all of that… are all written off in the same quarter.”
• Order book horizon change rationale: “5-year period is very small… we changed the period to a 10-year period.”

6. Red Flags / Positive Signals

Red flags
– Limited specificity on RFQ conversion: No L1/L2 disclosure; conversion timing remains “lag depending on criticality.”
– Order book jump explanation relies on horizon change: While logical, it can inflate perceived momentum; they also state order book is “point in time” and excludes daily closures.
– Aftermarket growth not quantified: Strong synergy claims but no numeric targets; “not going to commit numbers.”
– Supply chain risk minimized without concrete mitigation details: “not exposed as much” lacks evidence (no material/supplier mapping).

Positive signals
– Clear operational levers: R&D write-off acknowledged; operating leverage and mix improvements tied to margin direction.
– Capacity expansion discipline: capex schedule “on track,” greenfield groundwork on schedule, training facility ahead of schedule.
– Customer qualification progress: medical certification received; aerospace build-to-spec certification obtained; defence mass production commenced.

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

a. Change in Tone Over Time

• More Optimistic (vs earlier calls).
• Q2 FY26 / Q3 FY26 calls emphasized macro uncertainty (tariffs, logistics, alloy volatility) and “temporary scheduling delays.”
• Current Q1 FY27 call leans heavily into trade tailwinds and “sharp demand revival,” with less emphasis on near-term headwinds.
• What changed:
• More confidence in export order revival (CETA + U.S. tariff rollback narrative).
• More emphasis on conversion readiness (backlog → executable volumes) and visibility (10-year order book).

b. Tracking Past Commitments vs Outcomes

• Capex funding / no equity raise unless inorganic opportunities
• Past (Q4 FY26 call, May 05 2026): Management said internal accruals/debt capacity sufficient; equity raise only if inorganic opportunities arise.
• Current (Q1 FY27 call): Warrants issued; management says it’s for inorganic flexibility.
• Flag: ⏳ Delayed / reframed (equity-like instrument now used, but justified as inorganic optionality; no inorganic deal disclosed yet).
• Greenfield commissioning timeline
• Past (Q4 FY26 call): commercial production “late 2027” (second half / last quarter FY28 calendar framing).
• Current: still “late 2027” and groundwork on track; training facility ahead of schedule.
• Flag: ✅ Consistent / on track.
• EBITDA margin stabilization narrative
• Past: margins pressured by non-operating income changes and one-time items; operating leverage expected to improve.
• Current: margin compression attributed to R&D write-offs; stabilization expected as programs transition.
• Flag: ✅ Narrative consistent (still “temporary” explanations), but no hard FY27 margin number.

c. Narrative Shifts

• From “macro headwinds” to “trade tailwinds”:
• Earlier calls highlighted U.S. tariff friction and logistics complexity; current call foregrounds tariff rollbacks and UK FTA benefits.
• Order book framing becomes more prominent and larger:
• 5-year order book → 10-year order book with a much larger figure; management now stresses “longer visibility.”
• Aftermarket becomes a new growth pillar:
• Not a major focus in earlier transcripts; now positioned as a Q2 FY27 rollout with synergy claims.

d. Consistency & Credibility Signals

• Medium credibility.
• Strength: management repeatedly explains margin movements with consistent accounting logic (R&D write-offs; operating leverage).
• Weakness: order book growth is explained via horizon change and “point in time,” which can reduce comparability; RFQ conversion remains non-quantified.

e. Evolution of Key Themes

• Demand / exports: Improving (from “tariff/logistics delays” → “sharp demand revival”).
• Margins: Mixed—improving operating leverage story, but current quarter includes “temporary compression” from R&D.
• Expansion: Stable—capex and Andhra timeline remain consistent.
• Value-chain upgrade: Consistent—components → subsystems → more vertical integration; now explicitly includes heat treatment and special processes in Andhra.
• Diversification: New emphasis on aftermarket and defence strategy execution.

f. Additional Insights (cross-period intelligence)

• Risk is shifting from “external tariffs” to “execution/qualification & cost pass-through”:
• Current call downplays supply chain bottlenecks but acknowledges logistics cost increases, tool costs, and wage increases—suggesting margin risk may be migrating from demand uncertainty to cost inflation and customer negotiation timing.
• R&D write-off remains a recurring explanation:
• Management continues to justify margin pressure as investment; investors should watch whether “stabilize” happens in subsequent quarters.